Skip to main content
Clinical Trials/NL-OMON25423
NL-OMON25423
Recruiting
Not Applicable

A randomized controlled trial to compare near-infrared fluorescence imaging with standard-of-care sentinel lymph node mapping in vulvar cancer patients

eiden University Medical Center (LUMC)0 sites48 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eiden University Medical Center (LUMC)
Enrollment
48
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Crane LM, Themelis G, Arts HJ et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol 2011;120:291-295.
- Schaafsma BE, Verbeek FP, Peters AA et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers. BJOG 2013;120:758-764.
- Hutteman M, van der Vorst JR, Gaarenstroom KN et al. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol 2012;206:89-5

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
eiden University Medical Center (LUMC)

Eligibility Criteria

Inclusion Criteria

  • T1 squamous cell carcinoma of the vulva (FIGO staging 2009\), with a depth of infiltration \>1 mm, \<4 cm in diameter, unifocal and not encroaching in urethra, vagina or anus, with clinically negative inguinofemoral LNs;
  • Localization and size of the tumor are such that peri\-lesional injection of the tracer at 3 or 4 sites is possible;

Exclusion Criteria

  • Patients with multifocal tumors of the vulva;
  • Patients who show enlarge (\>1\.5cm)/suspicious lymph nodes at preoperative imaging;

Outcomes

Primary Outcomes

Not specified

Similar Trials